Augment
Important Disclosure Information. Read Before Proceeding.
Companies
Fivetran
Fivetran
Oakland, CA
Founded 2012
Data management & analytics
Fivetran is a technology company that helps analysts replicate data into a cloud warehouse.
fivetran.com|X (Twitter)|LinkedIn|Crunchbase
Last Round Valuation
$5.6B
Last Round Share Price
$ XX.XY
Total Funding
$728M
Last Round
Series D

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

News

Hippocratic AI Raises $141 Million in Series B Funding, Partners with Fivetran for Secure Data Infrastructure thumbnail image
10/29/2025
Hippocratic AI Raises $141 Million in Series B Funding, Partners with Fivetran for Secure Data Infrastructure
Hippocratic AI's $141 million Series B funding, coupled with its partnership with Fivetran, positions it to enhance secure data infrastructure in healthcare, potentially transforming patient data management and driving innovation in AI-driven medical solutions.
Yahoo FinanceHIT Consultant
Fivetran Joins TechCrunch Disrupt 2024 to Enhance Brand Presence Amid Evolving Data Pipeline Landscape thumbnail image
10/22/2025
Fivetran Joins TechCrunch Disrupt 2024 to Enhance Brand Presence Amid Evolving Data Pipeline Landscape
Fivetran's participation in TechCrunch Disrupt 2024 signals its strategic intent to solidify market leadership and attract investment in a competitive data pipeline sector, potentially enhancing its valuation and growth prospects amid increasing demand for data integration solutions.
TechCrunchTechCrunch
Fivetran Surpasses $300 Million ARR in 2024, Partners with Hippocratic AI to Enhance Healthcare Data Infrastructure thumbnail image
10/09/2025
Fivetran Surpasses $300 Million ARR in 2024, Partners with Hippocratic AI to Enhance Healthcare Data Infrastructure
Fivetran's $300 million ARR milestone, coupled with its partnership with Hippocratic AI, positions it as a key player in the healthcare data sector, potentially reshaping data management standards and driving innovation in patient care analytics.
Digital Health NewsFinancialContent

Research

Fivetran One-Pager
Fivetran: the $200M/yr Zapier of ETL
Fivetran revenue, growth, and valuation
Conor McCarter, co-founder of Prequel, on Fivetran's existential risk
PostHog: the $9.5M/year anti modern data stack company
Databricks at $4B ARR growing 50% YoY
Thomas Schiavone, co-founder and CEO of Calixa, on the PLG data pipeline
Tristan Handy, CEO of dbt Labs, on dbt’s multi-cloud tailwinds
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How can I get notified when there are new interested buyers of my shares?
Are orders posted anonymously?
How do Augment fees work?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.